SCHEDULE 13G/A: Nantahala Capital Management Discloses 9.99% Stake in Verastem, Inc.

Nantahala Capital Management, along with Wilmot B. Harkey and Daniel Mack, has disclosed a 9.99% beneficial ownership stake in Verastem, Inc., totaling 5,459,278 shares, including shares acquirable via warrants.

Summary

• Nantahala Capital Management, LLC, Wilmot B. Harkey, and Daniel Mack (the "Reporting Persons") have filed an Amendment No. 2 to Schedule 13G regarding their beneficial ownership in Verastem, Inc.
• As of March 31, 2025, the Reporting Persons collectively beneficially own 5,459,278 shares of Verastem, Inc. Common Stock.
• This ownership represents 9.99% of the total outstanding shares of Verastem, Inc.
• The reported shares include 3,160,737 shares that can be acquired by the Reporting Persons within sixty days through the exercise of warrants.
• The Reporting Persons have shared voting power and shared dispositive power over all 5,459,278 shares.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Verastem, Inc.
• BLACKWELL PARTNERS LLC SERIES A, a fund advised by Nantahala, has the right to receive dividends or proceeds from the sale of more than five percent of the outstanding shares beneficially owned by Nantahala.

Sentiment

Score: 5

Explanation: This is a neutral regulatory filing disclosing beneficial ownership. It does not contain positive or negative operational news, but the continued significant stake by an institutional investor could be viewed as a minor positive signal.

Positives

• A significant institutional investor, Nantahala Capital Management, maintains a substantial stake in Verastem, Inc., indicating continued confidence or a long-term investment strategy.
• The inclusion of shares acquirable through warrants suggests potential future capital inflow to Verastem if these warrants are exercised.

Risks

• No specific risks related to Verastem, Inc.'s operations or financial health are mentioned in this ownership disclosure. The only inherent risk is the general market risk associated with holding shares.

Future Outlook

This Schedule 13G filing is a disclosure of current beneficial ownership and does not contain forward-looking statements or guidance regarding Verastem, Inc.'s future performance or strategic direction. It only indicates the potential acquisition of additional shares through warrant exercise within sixty days.

Management Comments

• The Reporting Persons certified that the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of Verastem, Inc.

Industry Context

This filing is a routine disclosure of a significant ownership stake by an institutional investor. It does not provide specific insights into Verastem, Inc.'s operational performance or broader industry trends, but rather reflects an investment decision by Nantahala Capital Management within the context of the public markets.

Comparison to Industry Standards

• This document is a standard Schedule 13G filing, which is a regulatory requirement for investors acquiring more than 5% beneficial ownership in a public company.
• The disclosed 9.99% stake is a significant position for an institutional investor, comparable to other large institutional holdings seen in publicly traded companies across various sectors.
• No specific comparable companies or projects are mentioned within this filing.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional stake may influence investor perception and potentially provide a degree of stability or confidence in the stock.
• Company (Verastem, Inc.): The potential exercise of warrants could lead to an increase in outstanding shares and capital for the company.

Next Steps

• The document indicates that 3,160,737 shares may be acquired by the Reporting Persons within sixty days through the exercise of warrants, which represents a potential future action by the investors.

Key Dates

Keywords

Verastem Inc., Nantahala Capital Management, Wilmot B. Harkey, Daniel Mack, Schedule 13G, beneficial ownership, common stock, institutional investor, warrants